Clinical Trial

Nivo40-AVD for Advanced Classic Hodgkin Lymphoma

Name: Nivo40-AVD for Advanced Classic Hodgkin Lymphoma — clinical trial record (NCT06984146)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The aim of the current trial is to evaluate the efficacy and safety of flat-dose nivolumab (40 mg) in combination with AVD in the management of patients with newly diagnosed advanced classic Hodgkin Lymphoma

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-05-19.

Trial Details

NCT Number	NCT06984146
Lead Sponsor	National Medical Research Radiological Centre of the Ministry of Health of Russia
Conditions	Hodgkin Lymphoma, Adult
Enrollment	54 participants
Start Date	2025-04-15
Primary Completion	2028-01 (estimated)
Study Completion	2029-01 (estimated)
Updated on ClinicalTrials.gov	2025-11-26